NorInnova Invest
NorInnova Invest AS, founded in 2007 and based in Tromsø, Norway, focuses on fund of funds and direct investments in early-stage companies primarily located in northern Norway. The firm specializes in sectors such as marine technology, aquaculture, biotechnology, information and communication technology, and energy. NorInnova Invest typically invests up to NOK 27 million in its portfolio companies and actively participates in their governance by taking board positions. The firm aims to exit investments through trade sales or initial public offerings within a four to six-year timeframe. Additionally, it collaborates with nationwide seed funds based in Oslo, Stavanger, Bergen, and Trondheim to support selected technology sectors. Although the fund ceased new investments as of January 1, 2013, it continues to engage in follow-up investments within its existing portfolio.
Vitux group manufacturers of dietary supplements within its segment.
Prophylix Pharma AS is a biotech company based in Tromso, Norway, that specializes in developing treatments aimed at preventing excessive bleeding in fetuses and newborns affected by fetal neonatal alloimmune thrombocytopenia (FNAIT). Established in 2008, the company focuses on addressing a critical medical need in neonatal care, providing innovative solutions to improve health outcomes for vulnerable infants.
ReSight AS, founded in 1994 and headquartered in Harstad, Norway, specializes in developing mobile client solutions tailored for fieldwork in the power industry. The company offers PowerCatch, a software platform that enhances project management and collaboration for clients in this sector. By focusing on mobile client services, ReSight aims to improve efficiency and documentation during field operations, providing tools that facilitate better collaboration among users in the power grid space.
Private Equity Round in 2011
Established in 1994, Dualog is a prominent provider of maritime data communications, specializing in software and services that enhance ship-to-shore connectivity. The company offers a comprehensive digital platform that ensures reliable and secure access to the internet, email, and cloud services onboard vessels. By streamlining operations and optimizing bandwidth, Dualog's solutions enable marine operators to manage their fleets more efficiently. Key features include data synchronization, remote access, web acceleration, and robust security measures, all designed to reduce operational costs and improve the overall use of communication resources, regardless of the carrier.
Calanus AS specializes in producing marine bioactives derived from the zooplankton Calanus finmarchicus, a renewable resource found in the Norwegian Sea. The company offers a range of products, including Calanus Hydrolysate, an extract made from gently processed Calanus finmarchicus; Calanus Oil, a bioactive omega-3 source; Calanus Freeze Dried, a lyophilized powder; Calanus Powder, a partially de-oiled dried form; and Calanus Sea Frozen, which is harvested and frozen fresh at sea. Established in 2002, Calanus AS is headquartered in Tromsø, Norway, and is dedicated to utilizing this sustainable marine resource for various applications.
Lytix Biopharma ASA is a clinical-stage biotechnology company based in Oslo, Norway, with an additional office in Tromso. Founded in 2003, the company specializes in developing innovative cancer immunotherapies designed to activate the patient's immune system against tumors. Its lead product, LTX-315, is an oncolytic peptide that modifies the tumor microenvironment by releasing potent immune stimulants and tumor antigens. In addition to LTX-315, Lytix Biopharma is also advancing other products in its pipeline, including LTX-401. The company is dedicated to research and development in the fields of cancer therapeutics and anti-microbials.
Orthogenics AS
Venture Round in 2008
Orthogenics AS aims to develop diagnostic and therapeutic methods for diagnosing and treating osteoarthritis.
Arena Norge AS has developed an integrated decision support system for Norwegian municipalities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.